Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
INGN
NGEN
Add up to 3 more stocks
INGN
Inogen, Inc.
-2.86%
$5.77-0.17Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$156.22M
52W Range
$5.04 - $9.13
NGEN
NervGen Pharma Corp. Common stock
-3.31%
$1.75-0.06Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$143.84M
52W Range
$1.58 - $6.30
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.89 | 11.81 |
| P/S Ratio | 0.44 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 48.9% | 0.0% |
| Operating Margin | -8.4% | 0.0% |
| Net Margin | -6.9% | 0.0% |
| ROE | -14.1% | -397.4% |
| ROA | -8.6% | -76.1% |
| ROIC | -13.9% | -223.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.74 | 1.23 |
| Quick Ratio | 2.34 | 1.23 |
| Debt/Equity | 0.09 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.